HCV linked to Parkinson’s disease?

Infection with hepatitis C virus (HCV) may increase the risk of developing Parkinson’s disease (PD), according to a study from Taiwan, reported in Neurology.

Researchers followed 49,967 people with viral hepatitis and 199,868 uninfected controls for an average of 12 years. Most hepatitis patients were infected with hepatitis B virus (71.3 per cent), while 20.6 per cent had HCV and 8.1 per cent both viruses.

After allowing for con-founders – including age, sex and co-morbidities – HCV positive people were 29 per cent more likely to develop PD than controls. People infected with hepatitis B or both viruses were no more or less likely to develop PD.

PD patients show marked neuroinflammation. Previous studies suggest that viral infections can trigger inflammation. The authors remark, however, that “additional clinical studies are required to confirm the association between HCV infection, neuroinflammation, and PD”.

Recommended

Oral impact

Welsh pharmacy flu jab success




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.